Clinical Trial

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Statins in patients with atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EEC) for conservative treatment.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-10-22; most recent amendment 2025-04-25.
Trial Details
NCT Number NCT06102863
Lead Sponsor Peking University People's Hospital
Collaborators: Beihang University, Peking University
Conditions Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
Enrollment 38 participants
Start Date 2023-04-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-29